Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pulmonary Hypertension, February 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 174 articles:
HTML format


 

Single Articles

  1. STEFFES LC, Kumar ME
    Chronic Daily House Dust Mite Exposure in Mice is an Effective Model to Quantify the Effect of Pharmacologic Agents on Discrete Stages of Artery Remodeling in Pulmonary Hypertension.
    Bio Protoc. 2022;12:e4273.
    PubMed    
    Abstract available

  2. FARRELL C, Balasubramanian A, Hays AG, Hsu S, et al
    A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;8:794706.
    PubMed    
    Abstract available

  3. WANG J, Zhang Z, Liang C, Lv T, et al
    Targeting Myadm to Intervene Pulmonary Hypertension on Rats Before Pregnancy Alleviates the Effect on Their Offspring's Cardiac-Cerebral Systems.
    Front Pharmacol. 2022;12:791370.
    PubMed    
    Abstract available

  4. ZHANG S, Tong X, Zhang T, Wang D, et al
    Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Front Cardiovasc Med. 2022;8:809594.
    PubMed    
    Abstract available

  5. KROEGER JR, Zollner J, Gerhardt F, Rosenkranz S, et al
    Detection of patients with chronic thromboembolic pulmonary hypertension by volumetric iodine quantification in the lung-a case control study.
    Quant Imaging Med Surg. 2022;12:1121-1129.
    PubMed    
    Abstract available

  6. ZHANG L, Dai J, Zhang P, Ma H, et al
    Right ventricular end-systolic remodeling index on cardiac magnetic resonance imaging: comparison with other functional markers in patients with chronic thromboembolic pulmonary hypertension.
    Quant Imaging Med Surg. 2022;12:894-905.
    PubMed    
    Abstract available

  7. TAMURA Y, Tamura Y
    Dasatinib-induced Pulmonary Hypertension.
    Intern Med. 2022 Feb 1. doi: 10.2169/internalmedicine.9107.
    PubMed    


  8. RASHIDI F, Parvizi R, Bilejani E, Mahmoudian B, et al
    Outcome of Surgery for Chronic Thromboembolic Pulmonary Disease without Pulmonary Hypertension.
    Thorac Cardiovasc Surg. 2022 Feb 2. doi: 10.1055/s-0041-1740560.
    PubMed    
    Abstract available

  9. SCHULZE KM, Weber RE, Horn AG, Colburn TD, et al
    Effects of pulmonary hypertension on microcirculatory hemodynamics in rat skeletal muscle.
    Microvasc Res. 2022 Jan 29:104334. doi: 10.1016/j.mvr.2022.104334.
    PubMed    
    Abstract available

  10. JOSEPH C, Berghausen EM, Behringer A, Rauch B, et al
    Coagulation-independent effects of thrombin and factor Xa: role of protease-activated receptors in pulmonary hypertension.
    Cardiovasc Res. 2022 Feb 1. pii: 6519149. doi: 10.1093.
    PubMed    
    Abstract available

  11. HUANG Y, Lin F, Tang R, Bao C, et al
    Gut Microbial Metabolite Trimethylamine N-Oxide Aggravates Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2022 Jan 31. doi: 10.1165/rcmb.2021-0414.
    PubMed    
    Abstract available

  12. YUAN YP, Yuan P, Su YL, Jiang R, et al
    Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Clin Rheumatol. 2022 Jan 31. pii: 10.1007/s10067-021-06016.
    PubMed    
    Abstract available

  13. CRITSER PJ, Boyer D, Visner GA, Collins SL, et al
    Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension.
    Pediatr Transplant. 2022 Jan 31:e14236. doi: 10.1111/petr.14236.
    PubMed    
    Abstract available

  14. LUONGO F, Miotti C, Scoccia G, Papa S, et al
    Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension.
    Heart Fail Rev. 2022 Jan 31. pii: 10.1007/s10741-021-10208.
    PubMed    
    Abstract available

  15. HATANO M, Abe K, Koike G, Takahashi T, et al
    Positive Predictors for Response to Ambrisentan Combination Therapy in Pulmonary Arterial Hypertension.
    Int Heart J. 2022;63:99-105.
    PubMed    
    Abstract available

  16. OKA T, Nakanishi R, Kabuki T, Hashimoto H, et al
    Appropriate Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension Improves Right Ventricular Ejection Fraction via Lung Perfusion Scan.
    Int Heart J. 2022;63:91-98.
    PubMed    
    Abstract available

  17. YE H, Wu Q, Zhang N, Shi J, et al
    The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension.
    Rheumatology (Oxford). 2022 Jan 30. pii: 6517499.
    PubMed    
    Abstract available

  18. CHEN D, Yuan T, Chen Y, Zhang H, et al
    DL0805-1, a novel Rho-kinase inhibitor, attenuates lung injury and vasculopathy in a rat model of monocrotaline-induced pulmonary hypertension.
    Eur J Pharmacol. 2022 Jan 26:174779. doi: 10.1016/j.ejphar.2022.174779.
    PubMed    
    Abstract available

  19. WANG Q, Sun YY, Huang YX, Wang L, et al
    Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men With Idiopathic Pulmonary Arterial Hypertension.
    Am J Mens Health. 2022;16:15579883211067084.
    PubMed    
    Abstract available

  20. MELZIG C, Rengier F
    [Increased pulmonary arterial and venous pressure].
    Radiologe. 2022;62:120-129.
    PubMed    
    Abstract available

  21. PENOV K, Radakovic D, Karimli S, Aleksic I, et al
    Fibrin Sealant Patch for the Management of Intractable Bleeding From an LVAD Apex Cannula.
    Heart Surg Forum. 2021;24:E1052-E1053.
    PubMed    
    Abstract available

  22. ARVANITAKI A, Diller GP
    The use of pulmonary arterial hypertension therapies in Eisenmenger syndrome.
    Expert Rev Cardiovasc Ther. 2021;19:1053-1061.
    PubMed    
    Abstract available

  23. ROLLER FC, Schussler A, Hasse A, Kriechbaum S, et al
    Effects of BPA on right ventricular mechanical dysfunction in patients with inoperable CTEPH - A cardiac magnetic resonance study.
    Eur J Radiol. 2021;147:110111.
    PubMed    
    Abstract available

  24. ZEYNALYAN AA, Kolasani B, Naik C, Sigakis CJG, et al
    Rapidly progressive respiratory failure after helminth larvae ingestion.
    BMC Pulm Med. 2021;21:422.
    PubMed    
    Abstract available

  25. WANG T, Duan Y, Liu D, Li G, et al
    The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension.
    Clin Exp Hypertens. 2021 Dec 10:1-8. doi: 10.1080/10641963.2021.2013493.
    PubMed    
    Abstract available

  26. XIN Z, Wang J, Li S, Sun C, et al
    A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension.
    Clin Exp Hypertens. 2021 Nov 25:1-6. doi: 10.1080/10641963.2021.1996590.
    PubMed    
    Abstract available

  27. DARDI F, Manes A, Guarino D, Zuffa E, et al
    A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Open Heart. 2021;8.
    PubMed    
    Abstract available

  28. DESHWAL H, Weinstein T, Sulica R
    Advances in the management of pulmonary arterial hypertension.
    J Investig Med. 2021;69:1270-1280.
    PubMed    
    Abstract available

  29. EL-KERSH K, Dickinson JD
    Pulmonary arterial hypertension: promising advances and remaining challenges.
    J Investig Med. 2021;69:1268-1269.
    PubMed    


  30. BERNAL-RAMIREZ J, Diaz-Vesga MC, Talamilla M, Mendez A, et al
    Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction.
    Oxid Med Cell Longev. 2021;2021:9993060.
    PubMed    
    Abstract available

  31. MANSUETO G, Di Napoli M, Campobasso CP, Slevin M, et al
    Pulmonary arterial hypertension (PAH) from autopsy study: T-cells, B-cells and mastocytes detection as morphological evidence of immunologically mediated pathogenesis.
    Pathol Res Pract. 2021;225:153552.
    PubMed    
    Abstract available

  32. SLOT E, Boers R, Boers J, van IJcken WFJ, et al
    Genome wide DNA methylation analysis of alveolar capillary dysplasia lung tissue reveals aberrant methylation of genes involved in development including the FOXF1 locus.
    Clin Epigenetics. 2021;13:148.
    PubMed    
    Abstract available

  33. HU W, Zhao F, Chen L, Ni J, et al
    NAADP-induced intracellular calcium ion is mediated by the TPCs (two-pore channels) in hypoxia-induced pulmonary arterial hypertension.
    J Cell Mol Med. 2021;25:7485-7499.
    PubMed    
    Abstract available

  34. SONG R, Lei S, Yang S, Wu SJ, et al
    LncRNA PAXIP1-AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis.
    J Cell Mol Med. 2021;25:7321-7334.
    PubMed    
    Abstract available

  35. WANG RS, Loscalzo J
    Network module-based drug repositioning for pulmonary arterial hypertension.
    CPT Pharmacometrics Syst Pharmacol. 2021;10:994-1005.
    PubMed    
    Abstract available

  36. TOUJANI S, El Ouni A, Belhassan A, Ghriss N, et al
    [A rare cause of pulmonary arterial hypertension: Thoracic amyloidosis].
    Ann Cardiol Angeiol (Paris). 2022;71:59-62.
    PubMed    
    Abstract available

  37. HU Z, Song Q, Ma H, Guo Y, et al
    TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.
    J Bioenerg Biomembr. 2021;53:309-320.
    PubMed    
    Abstract available

  38. CONDORI LEANDRO HI, Vakhrushev AD, Goncharova NS, Korobchenko LE, et al
    Stimulation Mapping of the Pulmonary Artery for Denervation Procedures: an Experimental Study.
    J Cardiovasc Transl Res. 2021;14:546-555.
    PubMed    
    Abstract available

  39. DOYTCHINOVA A, Gerson M
    First steps in imaging the right ventricle with iodine-123-metaiodobenzylguanidine (123I-MIBG) and cadmium-zinc-telluride technology.
    J Nucl Cardiol. 2021;28:557-559.
    PubMed    


  40. GIMELLI A, Pugliese NR, Bertasi M, Airo E, et al
    Cardio-pulmonary involvement in pulmonary arterial hypertension: A perfusion and innervation scintigraphic evaluation.
    J Nucl Cardiol. 2021;28:546-556.
    PubMed    
    Abstract available

  41. DENG L, Chen J, Chen B, Wang T, et al
    LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca2+]i in Pulmonary Arterial Smooth Muscle Cells.
    Am J Respir Cell Mol Biol. 2022 Feb 11. doi: 10.1165/rcmb.2020-0480.
    PubMed    
    Abstract available

  42. CHEN Y, Zhao Y, Tanba C, Qi G, et al
    Undersized ballooning strategy for chronic thrombo-embolic pulmonary hypertension.
    Eur Heart J Case Rep. 2022;6:ytac034.
    PubMed    


  43. PU S, Yin L, Wen B, He J, et al
    The Association of Body Mass Index With the Risk of Pulmonary Hypertension in Adults: A Systematic Review and Meta-Analysis of Observational Studies.
    Front Med (Lausanne). 2022;8:680223.
    PubMed    
    Abstract available

  44. SMOLDERS VFED, Rodriguez C, Blanco I, Szulcek R, et al
    Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Sci Rep. 2022;12:2283.
    PubMed    
    Abstract available

  45. ZHENG Z, Chen R, Sun X, Lu J, et al
    A Meta-analysis of the efficacy of pulmonary artery denervation in the treatment of pulmonary hypertension.
    Heart Lung. 2022;53:42-50.
    PubMed    
    Abstract available

  46. YOO HHB, Marin FL
    Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature.
    Int J Gen Med. 2022;15:1075-1083.
    PubMed    
    Abstract available

  47. SAVALE L, Huitema M, Shlobin O, Kouranos V, et al
    WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
    Eur Respir Rev. 2022;31.
    PubMed    
    Abstract available

  48. YAMASAKI Y, Moriyama S, Tatsumoto R, Abe K, et al
    Chronic thromboembolic pulmonary hypertension after acute pulmonary thromboembolism revealed by dynamic chest radiography.
    Eur Heart J Cardiovasc Imaging. 2022 Feb 7. pii: 6523881.
    PubMed    


  49. ALICI G, Genc O
    Prevalence and etiologies of pulmonary hypertension at Somalia-Turkey Training and Research Hospital in Mogadishu.
    Pan Afr Med J. 2021;40:215.
    PubMed    
    Abstract available

  50. TANG Y, Huo X, Liu J, Tang Y, et al
    MicroRNA-325-3p Targets Human Epididymis Protein 4 to Relieve Right Ventricular Fibrosis in Rats with Pulmonary Arterial Hypertension.
    Cardiovasc Ther. 2022;2022:4382999.
    PubMed    
    Abstract available

  51. FU WH, Chen PL, Xia JL, Fu L, et al
    [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:158-170.
    PubMed    
    Abstract available

  52. TANAKA S, Yamamoto T, Mikawa M, Nawata J, et al
    Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension.
    Heart Rhythm. 2022 Feb 5. pii: S1547-5271(22)00119.
    PubMed    
    Abstract available

  53. LUNARDI M, Wu S, Serruys PW, Onuma Y, et al
    Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms.
    ESC Heart Fail. 2022 Feb 7. doi: 10.1002/ehf2.13819.
    PubMed    
    Abstract available

  54. GAMRACY J, Wiggen K, Vientos-Plotts A, Reinero C, et al
    Clinicopathologic features, comorbid diseases, and prevalence of pulmonary hypertension in dogs with bronchomalacia.
    J Vet Intern Med. 2022 Feb 7. doi: 10.1111/jvim.16381.
    PubMed    
    Abstract available

  55. OH S, Jung JH, Ahn KJ, Jang AY, et al
    Stem Cell and Exosome Therapy in Pulmonary Hypertension.
    Korean Circ J. 2022;52:110-122.
    PubMed    
    Abstract available

  56. GUO W, Wang N, Cui Z, Liu W, et al
    Clinical Value of FeNO for Pulmonary Hypertension Diagnosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Emerg Med Int. 2022;2022:9924047.
    PubMed    
    Abstract available

  57. BLANQUEZ-NADAL M, Piliero N, Guillien A, Salvat M, et al
    Neural respiratory drive in chronic thromboembolic pulmonary hypertension: Effect of balloon pulmonary angioplasty.
    Respir Physiol Neurobiol. 2022;299:103857.
    PubMed    
    Abstract available

  58. WHITLOCK AE, Sheils CA, Zalieckas JM, Visner G, et al
    High altitude simulation testing in patients with congenital diaphragmatic hernia.
    J Pediatr Surg. 2021 Oct 29. pii: S0022-3468(21)00743.
    PubMed    
    Abstract available

  59. MACHADO RD, Southgate L
    Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available

  60. CERIK IB, Dindas F, Koyun E, Dereli S, et al
    New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid.
    Clin Biochem. 2022;100:22-28.
    PubMed    
    Abstract available

  61. JANSEN SMA, van de Heuvel LM, Houweling AC, van Tintelen JP, et al
    Uptake and Patient Perspectives on Additional Testing for Novel Disease-Associated Genes: Lessons from a PAH Cohort.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available

  62. ZHU H, Sun X, Cao Y, Pudasaini B, et al
    Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH.
    BMC Pulm Med. 2021;21:324.
    PubMed    
    Abstract available

  63. ZHANG R, Li Z, Liu C, Yang Q, et al
    Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells.
    J Ethnopharmacol. 2022;283:114734.
    PubMed    
    Abstract available

  64. CORBOZ MR, Plaunt AJ, Malinin V, Li Z, et al
    Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
    Eur J Pharmacol. 2021 Sep 8:174484. doi: 10.1016/j.ejphar.2021.174484.
    PubMed    
    Abstract available

  65. XU J, Wen X, Fu Z, Jiang Y, et al
    Chronic hypoxia promoted pulmonary arterial smooth muscle cells proliferation through upregulated calcium-sensing receptorcanonical transient receptor potential 1/6 pathway.
    Microcirculation. 2021;28:e12715.
    PubMed    
    Abstract available

  66. HEKIMSOY V, Kilinc Hekimsoy H, Sekeroglu MA, Kaya EB, et al
    The relationship between retinal microcirculation and right heart catheterization and echocardiography findings in patients with idiopathic pulmonary arterial hypertension.
    Microcirculation. 2021;28:e12704.
    PubMed    
    Abstract available

  67. LEE A, Patterson KA, Tan DJ, Wilson ME, et al
    Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients.
    Scand J Rheumatol. 2021;50:469-474.
    PubMed    
    Abstract available

  68. MIYAMOTO K, Inai K, Kobayashi T, Maeda J, et al
    Outcomes of idiopathic pulmonary arterial hypertension in Japanese children: a retrospective cohort study.
    Heart Vessels. 2021;36:1392-1399.
    PubMed    
    Abstract available

  69. HIRAM R, Xiong F, Naud P, Xiao J, et al
    The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Cardiovasc Res. 2021;117:1776-1789.
    PubMed    
    Abstract available

  70. ZHANG WT, Lu Q, Ding JJ, Gu M, et al
    Association of asymmetric dimethylarginine with the pathological process of persistent pulmonary hypertension of the newborn.
    Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:54-59.
    PubMed    
    Abstract available

  71. ABU T, Levi A, Hasdai D, Kramer MR, et al
    Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization.
    BMC Cardiovasc Disord. 2022;22:53.
    PubMed    
    Abstract available

  72. QUAN R, Huang S, Pang L, Shen J, et al
    Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics.
    BMC Cardiovasc Disord. 2022;22:56.
    PubMed    
    Abstract available

  73. YANG LF, Chen DD, Wang GF, Long YL, et al
    [Efficacy of fenestrated atrial septal defect occulders on pulmonary hypertension dogs].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:166-171.
    PubMed    
    Abstract available

  74. CIPOLLETTA S, Ravasio G, Bussotti M
    Sexual and Reproductive Health in Women with Pulmonary Hypertension: A Qualitative Study.
    Arch Sex Behav. 2022 Feb 14. pii: 10.1007/s10508-022-02284.
    PubMed    
    Abstract available

  75. SLAWEK-SZMYT S, Araszkiewicz A, Jankiewicz S, Smukowska-Gorynia A, et al
    Association of Electrocardiographic Signs of Right Ventricular Hypertrophy and Clot Localization in Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  76. ALBANI S, Stolfo D, Venkateshvaran A, Chubuchny V, et al
    Echocardiographic Biventricular Coupling Index to Predict Pre-Capillary Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2022 Feb 11. pii: S0894-7317(22)00061.
    PubMed    
    Abstract available

  77. BERLIER C, Saxer S, Lichtblau M, Schneider SR, et al
    Influence of Upright Versus Supine Position on Resting and Exercise Hemodynamics in Patients Assessed for Pulmonary Hypertension.
    J Am Heart Assoc. 2022;11:e023839.
    PubMed    
    Abstract available

  78. CHEN YJ, Lin YJ, Guo MM
    Pediatric Lupus Presenting as Pulmonary Hypertension, Myocarditis, and Massive Pericardial Effusion in an 11-Year-Old Girl: A Case Report and Literature Review.
    Front Pediatr. 2022;10:772422.
    PubMed    
    Abstract available

  79. ALSOMALI F, Mushtaq S, Bakir M, Almustanyir S, et al
    Fruitful Pregnancy Outcome in a Case of Eisenmenger Syndrome With Severe Pulmonary Hypertension: A Rare Case Report.
    Cureus. 2022;14:e21068.
    PubMed    
    Abstract available

  80. MEHRA P, Mehta V, Yusuf J, Sukhija R, et al
    Endothelin-1 gene and endothelin receptor A gene polymorphisms in severe pulmonary hypertension associated with rheumatic mitral valve disease.
    Arch Med Sci. 2022;18:260-266.
    PubMed    
    Abstract available

  81. AGUIRRE-FRANCO C, Torres-Duque CA, Salazar G, Casas A, et al
    Prevalence of pulmonary hypertension in COPD patients living at high altitude.
    Pulmonology. 2022 Feb 9. pii: S2531-0437(22)00004.
    PubMed    
    Abstract available

  82. JASINSKA-STROSCHEIN M
    A review of genetically-driven rodent models of pulmonary hypertension.
    Vascul Pharmacol. 2022 Feb 9:106970. doi: 10.1016/j.vph.2022.106970.
    PubMed    
    Abstract available

  83. INDRALINGAM CS, Gutierrez-Gonzalez AK, Johns SC, Tsui T, et al
    IL-33/ST2 receptor-dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice.
    Physiol Rep. 2022;10:e15185.
    PubMed    
    Abstract available

  84. SHI Q, Wang Z, Yang N, Ma Y, et al
    Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Ann Palliat Med. 2022;11:339-351.
    PubMed    
    Abstract available

  85. BELENJE A, Agarwal K
    Bilateral central retinal vein occlusion in a neonate secondary to atrial septal defect and patent ductus arteriosus.
    BMJ Case Rep. 2022;15.
    PubMed    


  86. LEE JY, Lee SH, Kim WH
    Reversible severe tricuspid regurgitation associated with Graves' disease: A case report.
    Medicine (Baltimore). 2021;100:e28432.
    PubMed    
    Abstract available

  87. HUMBERT M, Montani D, Savale L, Tu L, et al
    [Targeting activin receptor IIA ligands for the treatment of pulmonary arterial hypertension].
    Med Sci (Paris). 2021;37:839-843.
    PubMed    


  88. LI A, He J, Zhang Z, Jiang S, et al
    Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available

  89. EYRIES M, Girerd B, Savale L, Soubrier F, et al
    A CELSR1 variant in a patient with pulmonary arterial hypertension.
    Clin Genet. 2021;100:771-772.
    PubMed    


  90. JOUEN-TACHOIRE TRH, Tucker SJ, Tammaro P
    Ion channels as convergence points in the pathology of pulmonary arterial hypertension.
    Biochem Soc Trans. 2021;49:1855-1865.
    PubMed    
    Abstract available

  91. ARAI MA, Sakuraba K, Makita Y, Hara Y, et al
    Evaluation of Naturally Occurring HIF-1 Inhibitors for Pulmonary Arterial Hypertension.
    Chembiochem. 2021;22:2799-2804.
    PubMed    
    Abstract available

  92. ARCOPINTO M, Marra AM
    Clinical and non-clinical determinants of pulmonary arterial hypertension development in severe autoimmune rheumatic diseases.
    Rheumatology (Oxford). 2021;61:1-2.
    PubMed    


  93. ZHU N, Swietlik EM, Welch CL, Pauciulo MW, et al
    Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Genome Med. 2021;13:80.
    PubMed    
    Abstract available

  94. KATEWA A, Sahu B, Gajpal S, Anderson RH, et al
    Total Anomalous Pulmonary Venous Connection and Aortopulmonary Window: Successful Management of a Rare Association.
    World J Pediatr Congenit Heart Surg. 2021;12:785-787.
    PubMed    
    Abstract available

  95. COONS JC, Crisamore K, Adams S, Modany A, et al
    A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2021;15:17534666211013688.
    PubMed    
    Abstract available

  96. SANTOS-MARTINEZ LE, Gomez-Tejada RA, Murillo-Jauregui CX, Hoyos-Paladines RA, et al
    [Chronic exposure to altitude. Clinical characteristics and diagnosis].
    Arch Cardiol Mex. 2021;91:500-507.
    PubMed    
    Abstract available

  97. CAI M, Li X, Dong H, Wang Y, et al
    CCR7 and its related molecules may be potential biomarkers of pulmonary arterial hypertension.
    FEBS Open Bio. 2021;11:1565-1578.
    PubMed    
    Abstract available

  98. MALONEY MA, Davidson Ward SL, Su JA, Durazo-Arvizu RA, et al
    Prevalence of pulmonary hypertension on echocardiogram in children with severe obstructive sleep apnea.
    J Clin Sleep Med. 2022 Feb 28. doi: 10.5664/jcsm.9944.
    PubMed    
    Abstract available

  99. SORENSEN HT, Skajaa N, Klok FA, Laugesen K, et al
    Cancer Risk in Pulmonary Hypertension Patients.
    Clin Epidemiol. 2022;14:173-177.
    PubMed    
    Abstract available

  100. KARAM N, Hausleiter J
    Can Artificial Intelligence Solve Pulmonary Hypertension Paradox in Severe Tricuspid Regurgitation?
    JACC Cardiovasc Interv. 2022;15:395-396.
    PubMed    


  101. FORTMEIER V, Lachmann M, Korber MI, Unterhuber M, et al
    Solving the Pulmonary Hypertension Paradox in Patients With Severe Tricuspid Regurgitation by Employing Artificial Intelligence.
    JACC Cardiovasc Interv. 2022;15:381-394.
    PubMed    
    Abstract available

  102. SHARMA M, Callan E, Konduri GG
    Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn.
    Clin Perinatol. 2022;49:103-125.
    PubMed    
    Abstract available

  103. DZIKOWSKA-DIDUCH O, Kurnicka K, Lichodziejewska B, Zdonczyk O, et al
    A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  104. VRIGKOU E, Vassilatou E, Dima E, Langleben D, et al
    The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  105. RUARO B, Baratella E, Caforio G, Confalonieri P, et al
    Chronic Thromboembolic Pulmonary Hypertension: An Update.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  106. EBERHARD M, McInnis M, de Perrot M, Lichtblau M, et al
    Dual-Energy CT Pulmonary Angiography for the Assessment of Surgical Accessibility in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  107. COLON HIDALGO D, Elajaili H, Suliman H, George MP, et al
    Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension.
    Antioxidants (Basel). 2022;11.
    PubMed    
    Abstract available

  108. BARBAGELATA L, Masson W, Bluro I, Lobo M, et al
    Prognostic role of cardiopulmonary exercise testing in pulmonary hypertension: a systematic review and meta-analysis.
    Adv Respir Med. 2022 Feb 24. pii: VM/OJS/J/84602. doi: 10.5603/ARM.a2022.0030.
    PubMed    
    Abstract available

  109. ARIF R, Pandey A, Zhao Y, Arsenault-Mehta K, et al
    Treatment of pulmonary hypertension associated with COPD: a systematic review.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  110. XIE SS, Deng Y, Guo SL, Li JQ, et al
    Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation.
    Sci Rep. 2022;12:3056.
    PubMed    
    Abstract available

  111. WANG L, Han X, Wang M, Ma X, et al
    Ventilation/perfusion imaging predicts response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Ann Nucl Med. 2022 Feb 22. pii: 10.1007/s12149-022-01731.
    PubMed    
    Abstract available

  112. ZHUANG XL, Zhu ZL, Huang QH, Yan FR, et al
    High magnesium mitigates the vasoconstriction mediated by different types of calcium influx from monocrotaline-induced pulmonary hypertensive rats.
    Exp Physiol. 2022 Feb 22. doi: 10.1113/EP090029.
    PubMed    
    Abstract available

  113. PUEBLA-ALDAMA D, Cueto-Robledo G, Barragan-Martinez MD, Roldan-Valadez E, et al
    Review of functional status and hemodynamic parameters in patients diagnosed with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) with and without Antiphospholipid Syndrome (APLS).
    Curr Probl Cardiol. 2022 Feb 19:101154. doi: 10.1016/j.cpcardiol.2022.101154.
    PubMed    
    Abstract available

  114. VOS JL, Leiner T, van Dijk APJ, van der Zwaan HB, et al
    Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension.
    Int J Cardiovasc Imaging. 2022 Feb 21. pii: 10.1007/s10554-022-02555.
    PubMed    
    Abstract available

  115. CHEN D, Zhang HF, Yuan TY, Sun SC, et al
    Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.
    Acta Pharmacol Sin. 2022 Feb 21. pii: 10.1038/s41401-022-00865.
    PubMed    
    Abstract available

  116. YANG JH, Harada T, Choi KH, Kato T, et al
    Peripheral Venous Pressure-Assisted Exercise Stress Echocardiography in the Evaluation of Pulmonary Hypertension During Exercise in Patients With Suspected Heart Failure With Preserved Ejection Fraction.
    Circ Heart Fail. 2022 Feb 22:CIRCHEARTFAILURE121009028.
    PubMed    
    Abstract available

  117. KHAN Z, Mlawa G, Bashir M, Abumedian M, et al
    Resolution of Thyrotoxicosis-Associated Pulmonary Hypertension With Treatment of Thyrotoxicosis: A Case-Based Report and Literature Review.
    Cureus. 2022;14:e21304.
    PubMed    
    Abstract available

  118. YANG D, Wang L, Jiang P, Kang R, et al
    Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension.
    J Healthc Eng. 2022;2022:3247807.
    PubMed    
    Abstract available

  119. OTA H, Kamada H, Higuchi S, Takase K, et al
    Clinical Application of 4D Flow MR Imaging to Pulmonary Hypertension.
    Magn Reson Med Sci. 2022 Feb 19. doi: 10.2463/mrms.rev.2021-0111.
    PubMed    
    Abstract available

  120. ROBERTSON L, Bunclark K, Ross RM, Cannon J, et al
    The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertension.
    Chron Respir Dis. 2022;19:14799731221078473.
    PubMed    
    Abstract available

  121. KARADAVUT S, Cetin M
    A Novel Factor in Determining the Risk of Ischemic Cerebrovascular Events in Patients with Atrial Fibrillation: Pulmonary Hypertension.
    J Stroke Cerebrovasc Dis. 2022;31:106387.
    PubMed    
    Abstract available

  122. SEREDYUK VN, Vakaliuk IP, Seredyuk NM, Fedorov SV, et al
    CLINICAL PECULIARITIES AND PATHOGENETIC DETERMINANTS OF DEVELOPMENT AND PROGRESSION OF CHRONIC PULMONARY HEART WITH ARTERIAL HYPERTENSION.
    Wiad Lek. 2022;75.
    PubMed    
    Abstract available

  123. DONN SM
    Persistent pulmonary hypertension of the newborn: Historical perspectives.
    Semin Fetal Neonatal Med. 2022 Feb 14:101323. doi: 10.1016/j.siny.2022.101323.
    PubMed    
    Abstract available

  124. KVASLERUD AB, Gude E, Eriksen G, Andreassen AK, et al
    Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic Study.
    Circ Heart Fail. 2022 Feb 9:CIRCHEARTFAILURE121009253.
    PubMed    
    Abstract available

  125. REDAELLI S, Magliocca A, Malhotra R, Ristagno G, et al
    Nitric oxide: Clinical applications in critically ill patients.
    Nitric Oxide. 2022;121:20-33.
    PubMed    
    Abstract available

  126. MUSSA A, Carli D, Giorgio E, Villar AM, et al
    MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.
    Genes (Basel). 2021;13.
    PubMed    
    Abstract available

  127. QIN T, Kong B, Dai C, Xiao Z, et al
    Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
    Bioengineered. 2022;13:2697-2709.
    PubMed    
    Abstract available

  128. KITA T, Kitamura K
    Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.
    Hypertens Res. 2022;45:389-400.
    PubMed    
    Abstract available

  129. SHENG Y, Gong X, Zhao J, Liu Y, et al
    Effects of Crocin on CCL2/CCR2 Inflammatory Pathway in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    Am J Chin Med. 2022;50:241-259.
    PubMed    
    Abstract available

  130. PRISCO SZ, Hartweck LM, Rose L, Lima PDA, et al
    Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
    Circ Heart Fail. 2022;15:e008574.
    PubMed    
    Abstract available

  131. VONK NOORDEGRAAF A, Channick R, Cottreel E, Kiely DG, et al
    The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2022;15:240-253.
    PubMed    
    Abstract available

  132. FREED BH
    REPAIRing What We Can't See: The Need for Imaging Endpoints in PAH Clinical Trials.
    JACC Cardiovasc Imaging. 2022;15:254-256.
    PubMed    


  133. CHEN CY, Hung CC, Chiang CH, Tsa YC, et al
    Pulmonary arterial hypertension in the elderly population.
    J Chin Med Assoc. 2022;85:18-23.
    PubMed    
    Abstract available

  134. PRISCO SZ, Eklund M, Moutsoglou DM, Prisco AR, et al
    Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2021;10:e022722.
    PubMed    
    Abstract available

  135. JAMIESON KL, Rose RA
    New insights into ventricular arrhythmogenesis in a pure model of pulmonary arterial hypertension.
    Heart Rhythm. 2022;19:125-126.
    PubMed    


  136. OTSUKI S, Saito T, Taylor S, Li D, et al
    Monocyte-released HERV-K dUTPase engages TLR4 and MCAM causing endothelial mesenchymal transition.
    JCI Insight. 2021;6.
    PubMed    
    Abstract available

  137. WUTTGE DM, Carlsen AL, Teku G, Wildt M, et al
    Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension.
    Rheumatology (Oxford). 2021;61:309-318.
    PubMed    
    Abstract available

  138. SINGH S, Lewis MI
    Evaluating the Right Ventricle in Acute and Chronic Pulmonary Embolism: Current and Future Considerations.
    Semin Respir Crit Care Med. 2021;42:199-211.
    PubMed    
    Abstract available

  139. BOON GJAM, Huisman MV, Klok FA
    Determinants and Management of the Post-Pulmonary Embolism Syndrome.
    Semin Respir Crit Care Med. 2021;42:299-307.
    PubMed    
    Abstract available

  140. HAHN J, Virk HUH, Al-Azzam F, Greason K, et al
    Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic and End-Stage Kidney Disease.
    Am J Cardiol. 2021 Nov 22. pii: S0002-9149(21)01061.
    PubMed    
    Abstract available

  141. CHRISTOU H, Khalil RA
    Mechanisms of Pulmonary Vascular Dysfunction in Pulmonary Hypertension and Implications for Novel Therapies.
    Am J Physiol Heart Circ Physiol. 2022 Feb 25. doi: 10.1152/ajpheart.00021.2022.
    PubMed    
    Abstract available

  142. BAZAN IS, Ardito TA, Zhang Y, Shan P, et al
    Sex Differences and Altered Mitophagy in Experimental Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2022 Feb 9. doi: 10.1152/ajplung.00019.2020.
    PubMed    
    Abstract available

  143. SHARMA S, Lang IM
    More Evidence for Inflammatory Thrombosis in Chronic Thromboembolic Pulmonary Hypertension - Is the Embolic Hypothesis Losing Grounds?
    Am J Respir Crit Care Med. 2022 Feb 8. doi: 10.1164/rccm.202201-0001.
    PubMed    


  144. KOLAITIS NA, Lammi M, Mazimba S, Feldman J, et al
    Human Immune Deficiency Virus-Associated Pulmonary Arterial Hypertension: A Report from the Pulmonary Hypertension Association Registry.
    Am J Respir Crit Care Med. 2022 Feb 18. doi: 10.1164/rccm.202111-2481.
    PubMed    


  145. JUNG SM, Park KS, Kim KJ
    Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
    Ann Rheum Dis. 2022;81:108-116.
    PubMed    
    Abstract available

  146. BALKI I, de Perrot M, Bavaghar-Zaeimi F, Nourouzpour S, et al
    Clinical Implications of Body Composition and Exercise Capacity Following Pulmonary Endarterectomy.
    Ann Thorac Surg. 2022;113:444-451.
    PubMed    
    Abstract available

  147. KOVACS G, Avian A, Bachmaier G, Troester N, et al
    Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach.
    Chest. 2022 Jan 26. pii: S0012-3692(22)00192-1. doi: 10.1016/j.chest.2022.
    PubMed    
    Abstract available

  148. JOHNSON SW, Maron BA
    COUNTERPOINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? No.
    Chest. 2022;161:313-315.
    PubMed    


  149. KOVACS G
    POINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? Yes.
    Chest. 2022;161:311-312.
    PubMed    


  150. RAHAGHI FF, Kolaitis NA, Adegunsoye A, de Andrade J, et al
    Screening Strategies for Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Multidisciplinary Delphi Study.
    Chest. 2022 Feb 14. pii: S0012-3692(22)00262-8. doi: 10.1016/j.chest.2022.
    PubMed    
    Abstract available

  151. LANE T, Hountras P
    A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
    Chest. 2022;161:e29-e34.
    PubMed    
    Abstract available

  152. MURRAY E, Taylor J, Hountras P
    A Case of High-Output Heart Failure.
    Chest. 2022;161:e23-e28.
    PubMed    
    Abstract available

  153. LECHARTIER B, Berrebeh N, Huertas A, Humbert M, et al
    Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy.
    Chest. 2022;161:219-231.
    PubMed    
    Abstract available

  154. ALQALYOOBI S, Liao SY, Qureshi W, Obi ON, et al
    National Temporal Trends in Hospitalization and Inpatient Mortality in Patients With Pulmonary Sarcoidosis in the United States Between 2007 and 2018.
    Chest. 2022;161:152-168.
    PubMed    
    Abstract available

  155. VEITH C, Varturk-Ozcan I, Wujak M, Hadzic S, et al
    Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Circulation. 2022 Feb 17. doi: 10.1161/CIRCULATIONAHA.121.057001.
    PubMed    
    Abstract available

  156. GAZENGEL P, Hascoet S, Amsallem M, Savale L, et al
    Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension.
    Eur Respir J. 2021 Nov 4. pii: 13993003.02388-2021.
    PubMed    


  157. RADVANSKY BM, Shah R, Feinman J, Augoustides JG, et al
    Pulmonary Hypertension in Pregnancy: A Positive Outcome with a Multidisciplinary Team and Individualized Treatment Plan.
    J Cardiothorac Vasc Anesth. 2022 Jan 3. pii: S1053-0770(21)01120.
    PubMed    


  158. DUMITRESCU D, Koster A, Erdoes G, Denault AY, et al
    Perioperative Management of Pulmonary Hypertension During Cardiac Surgery: A Call for Interdisciplinary Networking.
    J Cardiothorac Vasc Anesth. 2022 Jan 17. pii: S1053-0770(22)00048.
    PubMed    


  159. STEIN ML, Staffa SJ, O'Brien Charles A, Callahan R, et al
    Anesthesia in Children With Pulmonary Hypertension: Clinically Significant Serious Adverse Events Associated With Cardiac Catheterization and Noncardiac Procedures.
    J Cardiothorac Vasc Anesth. 2022 Jan 13. pii: S1053-0770(22)00044.
    PubMed    
    Abstract available

  160. LUO S, Kan J, Zhang J, Ye P, et al
    Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    J Cardiovasc Pharmacol. 2021;78:253-262.
    PubMed    
    Abstract available

  161. KEMELBEKOV K, Musaev Y, Bektenova G, Datkayeva G, et al
    Comparative Results of Treatment and Complications: Pedea in Open Ductus Arteriosus in Premature Infants.
    J Cardiovasc Pharmacol. 2021;78:e722-e728.
    PubMed    
    Abstract available

  162. ADIE SK, Abdul-Aziz AA, Ketcham SW, Moles VM, et al
    Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98139.
    PubMed    
    Abstract available

  163. KHIRFAN G, Li M, Wang X, Dweik RA, et al
    Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?
    J Heart Lung Transplant. 2021;40:614-622.
    PubMed    
    Abstract available

  164. JEROME LP, Severine F, Olaf M, Pauline P, et al
    Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France.
    J Heart Lung Transplant. 2021 Mar 26. pii: S1053-2498(21)02239.
    PubMed    
    Abstract available

  165. IRELAND CG, Damico RL, Kolb TM, Mathai SC, et al
    Exercise right ventricular ejection fraction predicts right ventricular contractile reserve.
    J Heart Lung Transplant. 2021;40:504-512.
    PubMed    
    Abstract available

  166. AIRHART S, Badie N, Doyle M, Correa-Jacque P, et al
    Assessing hemodynamic response to submaximal exercise in pulmonary arterial hypertension patients using an implantable hemodynamic monitor.
    J Heart Lung Transplant. 2021;40:430-434.
    PubMed    
    Abstract available

  167. HUG KP, Gerry Coghlan J, Cannon J, Taboada D, et al
    Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment.
    J Heart Lung Transplant. 2021;40:1223-1234.
    PubMed    
    Abstract available

  168. FURFARO D, Rosenzweig EB, Shah L, Robbins H, et al
    Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.
    J Heart Lung Transplant. 2021 Aug 25. pii: S1053-2498(21)02459.
    PubMed    
    Abstract available

  169. BENAZZO A, Bajorek L, Morscher A, Schrutka L, et al
    Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
    J Thorac Cardiovasc Surg. 2021 Jun 1. pii: S0022-5223(21)00879.
    PubMed    
    Abstract available

  170. LUKS AM, Hackett PH
    Medical Conditions and High-Altitude Travel.
    N Engl J Med. 2022;386:364-373.
    PubMed    


  171. BARBEAU S, Porto Ribeiro T, Gilbert G, Cardouat G, et al
    [Involvement of the Piezo1 and TRPV4 stretch-activated channels in pulmonary hypertension].
    Rev Mal Respir. 2022 Feb 9. pii: S0761-8425(22)00034.
    PubMed    
    Abstract available

  172. HEUKELS P, Corneth OBJ, van Uden D, van Hulst JAC, et al
    Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.
    Thorax. 2021;76:1209-1218.
    PubMed    
    Abstract available

  173. POVEDA D, Ruiz E, Fernandez AM, Gonzalez FJ, et al
    Lung Transplantation in a Young Patient With Pulmonary Artery Hypertension After Arterial Switch Operation: A Case Report.
    Transplant Proc. 2021 Dec 16. pii: S0041-1345(21)00820.
    PubMed    
    Abstract available

  174. TAKIGAMI M, Tsubata H, Nakanishi N, Matsubara Y, et al
    The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension.
    PLoS One. 2022;17:e0263244.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;